AGILE THERAPEUTICS INC (AGRX) Stock Income Statement
NASDAQ:AGRX - Nasdaq - US00847L3087 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.97M | 10.88M | 4.10M | 750.00K | 0.00 | |||
| Cost Of Goods | 8.44M | 6.84M | 10.72M | 280.00K | N/A | |||
| Gross Profit | 11.54M | 4.05M | -6.62M | 470.00K | N/A | |||
| Operating Expenses | 34.24M | 45.48M | 64.39M | 49.52M | 18.86M | |||
| Research and Development | 2.52M | 3.25M | 6.25M | 13.50M | 9.86M | |||
| Selling, General, and Administrative Expenses | 31.73M | 42.23M | 58.14M | 36.02M | 9.00M | |||
| Operating Income | -22.72M | -41.44M | -71.01M | -49.05M | -18.86M | |||
| Interest Income/Expense | 30.96M | 22.47M | -60.00K | -2.80M | 250.00K | |||
| Non Recurring Items | N/A | -11.12M | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | 8.24M | -30.09M | -71.07M | -51.85M | -18.61M | |||
| Income Tax | 0.00 | -4.68M | 0.00 | 0.00 | 0.00 | |||
| Net Income | 8.24M | -25.41M | -71.07M | -51.85M | -18.61M | |||
| EBITDA | -22.34M | -39.91M | -68.79M | -48.77M | -18.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 13.64 | -59.09 | -1.42K | -1.30K | -930.50 | |||
| Non GAAP EPS | -13.33 | N/A | -423.20 | -24.00 | -15.60 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.79% | 37.22% | -161.46% | 62.67% | N/A | |||
| Profit Margin | 41.26% | -233.55% | -1733.41% | -6913.33% | N/A | |||
| Operating Profit Margin | -113.77% | -380.88% | -1731.95% | -6540.00% | N/A | |||
All data in USD